Ansell Limited

ANN

Ansell Ltd. engages in the development, manufacture, distribution, and sale of gloves and protective personal equipment in the industrial and medical end markets. The company is headquartered in Richmond, Victoria and currently employs 15,951 full-time employees. The firm is an integrated manufacturer of personal protection equipment for healthcare and industrial workplaces. Its brands such as HyFlex, Ringers, MICROFLEX, TouchNTuff, GAMMEX, and AlphaTec. The firm is engaged in designing, developing, and manufacturing a range of hand, arm and body protection solutions and clothing. The firm operates through two segments: Healthcare Global Business Unit (GBU), and Industrial GBU. The Healthcare GBU segment is consists of surgical and examination gloves, healthcare safety devices and active infection prevention products for healthcare professionals and patients and single use industrial application gloves. The Industrial GBU segment comprises multi-use hand and body protection solutions for industrial worker environments and specialty applications. The firm operates other brands consists of the Kimtech, KleenGuard, The RightCycle Program, and APEX.

Appen Limited

APX

Appen Ltd. engages in the development of human-annotated datasets for machine learning and artificial intelligence. The company is headquartered in Chatswood, New South Wales and currently employs 992 full-time employees. The company went IPO on 2015-01-07. The firm is engaged in providing data services for deep learning and generative artificial intelligence (AI) systems. The firm operates through two segments: Global Services and New Markets. The Global Services represent the services that the Company provides to its five United States technology customers (Global customers) using the customer's data annotation platforms and tools. New Markets comprise Appen's data annotation platform and tools (Global Product), and the enterprise, government, and China business units. New Markets also include Quadrant geolocation and Point-of-Interest (POI) data capabilities. Its Annotation Platform is the platform that both customers and internal teams used to design, run and manage data annotation tasks. The firm serves various industries, including technology, automotive, financial services, healthcare, retail, and government agencies.

Carbonxt Group Limited

CG1

Carbonxt Group Ltd. engages in the development and marketing of activated carbon products. The company is headquartered in Gainesville Florida, Florida. The company went IPO on 2018-01-23. The firm is engaged in the development and sale of specialized Activated Carbon (AC) products, including Powdered Activated Carbon (PAC) and AC pellets for the removal of pollutants and toxins in industrial processes. Its products are used in industrial air purification, wastewater treatment and other liquid and gas phase markets, primarily for the capture of mercury and sulfur in order to reduce harmful emissions into the atmosphere. Its products include MATS-PAC, MATS-PACK S, CXT-WETJECT, CXT-NAQ-ACP, CEM-PAC, CEM-PAC-S, MACT-PAC, CXT-BB500, CXT-BB600, CXT-BB800, CXT-BB+, CXT-ACP60V, CXT-ACP50V, CXT-ACP45V, CXT-AQP50 and HYDRESTOR. The Company’s products application includes nutrient recovery technology, coal-fired power plants, cement plants, waste to energy: industrial boilers and incinerators, potable water, and volatile organic compounds (VOC) and contaminant removal.

CSL

CSL

CSL Ltd. is a biopharmaceutical company, which engages in the manufacture, marketing, and distribution of biopharmaceutical and allied products. The company is headquartered in Melbourne, Victoria and currently employs 30,398 full-time employees. The Company’s areas of focus include rare and serious diseases, influenza vaccines and iron deficiency and nephrology. The Company’s segments include CSL Behring, CSL Seqirus and CSL Vifor. The CSL Behring segment manufactures, markets and distributes plasma products, gene therapies and recombinants. The CSL Seqirus segment manufactures, markets and distributes predominantly influenza related products and provides pandemic services to governments. The CSL Vifor segment manufactures, markets and distributes products in the therapeutic areas of iron deficiency and nephrology. Its CSL Plasma operates plasma collection networks, with more than 325 plasma collection centers in the United States, Europe and China. The firm operates in Australia, the United States, Germany, the United Kingdom, Switzerland and China. Its products include Respreeza, Zemaira, HAEGARDA, KCENTRA, Hepatitis B, Evogam and others.

Vanguard MSCI Index International Shares ETF

VGS

VGS.AX was created on 2014-11-18 by Vanguard. The fund's investment portfolio concentrates primarily on total market equity. Vanguard MSCI International Shares Index ETF seeks to track the return of the MSCI World ex-Australia Index (with net dividends reinvested) in Australian dollars before taking into account fees, expenses and tax.